Solaris Vaccines Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $110K

  • Investors
  • 3

Solaris Vaccines General Information

Description

Operator of a medical research platform intended for vaccine development and research. The company uses photochemical (riboflavin/vitamin B2) in combination with UV light to rapidly and effectively disrupt the genetic material while preserving immune-stimulating proteins as well as carrying out specific nucleic acid alterations in pathogens such as viruses, bacteria, and parasites, enabling patients to get safe and effective vaccines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3185 Rampart Road
  • Fort Collins, CO 80521
  • United States
+1 (479)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3185 Rampart Road
  • Fort Collins, CO 80521
  • United States
+1 (479)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Solaris Vaccines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 19-May-2023 $110K Completed Generating Revenue
2. Accelerator/Incubator 20-May-2022 Completed Generating Revenue
1. Seed Round 07-Jan-2022 $500K $500K Completed Startup
To view Solaris Vaccines’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Solaris Vaccines Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Solaris Vaccines Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Colorado BioScience Association Not-For-Profit Venture Capital
CSU Starta Corporation Minority
VIC Technology Venture Development Venture Capital Minority
To view Solaris Vaccines’s complete investors history, request access »

Solaris Vaccines FAQs

  • When was Solaris Vaccines founded?

    Solaris Vaccines was founded in 2021.

  • Where is Solaris Vaccines headquartered?

    Solaris Vaccines is headquartered in Fort Collins, CO.

  • What is the size of Solaris Vaccines?

    Solaris Vaccines has 2 total employees.

  • What industry is Solaris Vaccines in?

    Solaris Vaccines’s primary industry is Drug Delivery.

  • Is Solaris Vaccines a private or public company?

    Solaris Vaccines is a Private company.

  • What is Solaris Vaccines’s current revenue?

    The current revenue for Solaris Vaccines is .

  • How much funding has Solaris Vaccines raised over time?

    Solaris Vaccines has raised $860K.

  • Who are Solaris Vaccines’s investors?

    Colorado BioScience Association, CSU Starta, and VIC Technology Venture Development have invested in Solaris Vaccines.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process